EBV Testing for Suspected Infectious Mononucleosis
For suspected infectious mononucleosis, order a heterophile antibody test (monospot) first, and if negative but clinical suspicion remains high, follow with EBV-specific serology including VCA-IgM, VCA-IgG, and EBNA-IgG antibodies.
Initial Testing Approach
The heterophile antibody test (monospot) serves as the frontline diagnostic tool for infectious mononucleosis in adolescents and young adults 1, 2. This test is:
- Rapid and inexpensive
- Sufficiently specific (approximately 90%) 3
- Adequate when positive in the appropriate clinical context
However, the monospot has important limitations: sensitivity is only 61.8% in pediatric populations 3, and up to 10% of patients with true infectious mononucleosis remain heterophile-negative 4. Young children are particularly likely to be heterophile-negative.
When to Order EBV-Specific Serology
Order EBV-specific antibody testing when:
- Monospot is negative but clinical presentation strongly suggests infectious mononucleosis
- Patient has atypical lymphocytes on peripheral blood smear with negative monospot
- Patient is a young child (heterophile antibodies less reliable)
- Confirmation of diagnosis is required for clinical decision-making
EBV-Specific Antibody Panel
The complete EBV serologic panel should include 4, 2:
1. VCA-IgM (Viral Capsid Antigen IgM)
- Appears early in acute infection
- Indicates recent/acute EBV infection
2. VCA-IgG (Viral Capsid Antigen IgG)
- Develops during acute illness
- Persists for life
3. EBNA-IgG (EBV Nuclear Antigen IgG)
- Appears during convalescence (weeks to months after onset)
- Absence with positive VCA-IgM confirms acute infection
Classic acute infectious mononucleosis pattern:
- VCA-IgM: Positive
- VCA-IgG: Positive
- EBNA-IgG: Negative (develops later)
Supportive Laboratory Findings
While not diagnostic alone, these findings support the diagnosis 1, 2:
- Peripheral blood leukocytosis with lymphocytes comprising ≥50% of differential
- Atypical lymphocytes >10% of total lymphocyte count
- Mild transaminase elevation (common)
Advanced Testing (Special Circumstances Only)
EBV PCR/viral load testing is NOT routinely indicated for uncomplicated infectious mononucleosis 5. Reserve quantitative EBV DNA testing for:
- Immunocompromised patients (transplant recipients, HIV)
- Suspected chronic active EBV infection
- Severe complications requiring monitoring
- Cases where serologic results remain inconclusive
Real-time PCR demonstrates high sensitivity 5, but detection of EBV DNA alone does not confirm active disease, as healthy individuals can have detectable viral DNA.
Critical Pitfalls to Avoid
Timing matters: Heterophile antibodies may not develop until 2-4 weeks into illness. If testing very early in the disease course, consider repeat testing in 1-2 weeks if initially negative 4.
Don't over-test: Avoid ordering EBV PCR for routine infectious mononucleosis diagnosis—it adds cost without improving clinical management in immunocompetent patients.
Beware false reassurance: A negative monospot does not rule out infectious mononucleosis, particularly in children under 12 years old 3. Clinical judgment combined with EBV-specific serology is essential.
Heterophile antibodies are not EBV-specific: They can occasionally be positive in other conditions, though this is uncommon 2.